Pfanstiehl Inc | FDA | Inspections | Form 483 | Warning Letters

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2023-01-23

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2023-01-23

Product
Web Link

02 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2023-01-23

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2023-01-23

Product
Web Link

03 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2017-10-05

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-10-05

Product
Web Link

04 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2017-10-05

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-10-05

Product
Web Link

05 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Monitoring of Marketed Animal Dr...

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

Product
Web Link

06 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Foodborne Biological Hazards

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

Product
Web Link

07 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

Product
Web Link

08 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2016-02-09

Product
Web Link

09 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2013-06-19

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Foodborne Biological Hazards

District Decision : No Action Indicated

Inspection End Date : 2013-06-19

Product
Web Link

10 FDA Audited

USA

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

District Decision : No Action Indicated

Inspection End Date : 2013-06-19

City : Waukegan

State : Illinois

Country/Area : U.S.A

Zip : 60085

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2013-06-19

Product
Web Link